ARKB vs. ARKG
ARKB (ARK 21Shares Bitcoin ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both exchange-traded funds - ARKB is a Cryptocurrency fund tracking the CME CF Bitcoin Reference Rate - New York Variant, while ARKG is a Health & Biotech Equities fund actively managed by ARK. ARKB is passively managed, while ARKG is actively managed. Over the past year, ARKB returned -44.16% vs 68.46% for ARKG. Their 0.37 correlation means their historical movements had little consistent relationship. ARKB charges 0.21%/yr vs 0.75%/yr for ARKG.
Performance
ARKB vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKB achieves a -26.69% return, which is significantly lower than ARKG's 40.49% return.
ARKB
- 1D
- 0.57%
- 1M
- 4.52%
- 6M
- -16.05%
- YTD
- -26.69%
- 1Y
- -44.16%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 10.02%
ARKG
- 1D
- 2.73%
- 1M
- -5.15%
- 6M
- 34.23%
- YTD
- 40.49%
- 1Y
- 68.46%
- 3Y*
- 6.19%
- 5Y*
- -14.37%
- 10Y*
- 8.50%
- ALL TIME*
- 6.67%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $32.37M | $33.70M | $41.78M | |
| $86.55M | $112.06M | $122.67M |
ARKB vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ARKB ARK 21Shares Bitcoin ETF | -26.69% | -6.59% | 86.54% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 40.49% | 23.04% | -26.95% |
Correlation
The correlation between ARKB and ARKG is 0.36, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.36 |
Correlation (All Time) Calculated using the full available price history since Jan 11, 2024 | 0.37 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKB vs. ARKG — Risk / Return Rank
ARKB
ARKG
ARKB vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK 21Shares Bitcoin ETF (ARKB) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKB | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.60 | ||
| Sortino ratioReturn per unit of downside risk | -3.79 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.26 | -0.43 |
| Calmar ratioReturn relative to maximum drawdown | -0.83 | 2.50 | -3.33 |
| Martin ratioReturn relative to average drawdown | -1.27 | 5.99 | -7.25 |
Loading charts...
Drawdowns
ARKB vs. ARKG - Drawdown Comparison
The maximum ARKB drawdown since its inception was -53.33%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for ARKB and ARKG.
Loading charts...
Drawdown Indicators
| ARKB | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.33% | -83.59% | +30.26% |
Max Drawdown (1Y)Largest decline over 1 year | -53.33% | -27.51% | -25.82% |
Max Drawdown (3Y)Largest decline over 3 years | — | -46.45% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -79.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | -48.94% | -63.58% | +14.64% |
Average DrawdownAverage peak-to-trough decline | -18.36% | -36.29% | +17.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.90% | 11.48% | +23.42% |
Volatility
ARKB vs. ARKG - Volatility Comparison
The current volatility for ARK 21Shares Bitcoin ETF (ARKB) is 8.21%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.16%. This indicates that ARKB experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKB | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.21% | 11.16% | -2.95% |
Volatility (6M)Calculated over the trailing 6-month period | 32.98% | 31.32% | +1.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.25% | 43.13% | +1.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 49.36% | 46.22% | +3.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.36% | 41.46% | +7.90% |
ARKB vs. ARKG - Expense Ratio Comparison
ARKB has a 0.21% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
ARKB vs. ARKG - Dividend Comparison
Neither ARKB nor ARKG has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKB ARK 21Shares Bitcoin ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
Frequently Asked Questions
ARKB and ARKG have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.16%) compared to ARKB (8.21%). In terms of maximum drawdown, ARKB dropped -53.33% vs ARKG's -83.59%.
On 1-year performance, ARKG leads with 68.46% vs -44.16% for ARKB. On fees, ARKB is cheaper at 0.21% per year. On volatility, ARKB has been the lower-risk option at 8.21%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, ARKG has performed better with a 68.46% return vs -44.16%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ARKB is cheaper with a 0.21% expense ratio, compared with 0.75% for ARKG.
ARKB and ARKG have nearly identical dividend yields, around 0.00%.
ARKB is categorized as Cryptocurrency, while ARKG is Health & Biotech Equities. Their fees differ too: 0.21% for ARKB and 0.75% for ARKG.
ARKG currently has the higher Sharpe Ratio (1.60 vs -1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKB and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer